CEL-SCI CORPORATION Other Current Liabilities
CEL-SCI CORPORATION (CVM) had Other Current Liabilities of $0 as of 2020-09-30, per its 10-K filed 2020-12-29.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2020-12-31
- 2020-09-30: Other Liabilities, Current $0.00.
- 2020-06-30: Other Liabilities, Current $0.00.
- 2020-03-31: Other Liabilities, Current $5.00K.
- 2019-12-31: Other Liabilities, Current $5.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2020-09-30 | $0.00 10-K · filed 2020-12-29 |
| 2020-06-30 | $0.00 10-Q/A · filed 2020-12-31 |
| 2020-03-31 | $5.00K 10-Q/A · filed 2020-12-30 |
| 2019-12-31 | $5.00K 10-Q/A · filed 2020-12-30 |
| 2019-09-30 | $14.96K 10-Q/A · filed 2020-12-31 |
| 2019-06-30 | $16.01K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $13.98K 10-Q · filed 2019-05-14 |
| 2018-12-31 | $13.77K 10-Q · filed 2019-02-14 |
| 2018-09-30 | $14.03K 10-K/A · filed 2019-12-23 |
| 2018-06-30 | $14.29K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $14.58K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $11.81K 10-Q · filed 2018-02-12 |
| 2017-09-30 | $12.45K 10-K · filed 2018-12-19 |
| 2017-06-30 | $10.87K 10-Q/A · filed 2017-12-11 |
| 2017-03-31 | $7.79K 10-Q/A · filed 2017-12-11 |
| 2016-12-31 | $7.20K 10-Q/A · filed 2017-12-11 |
| 2016-09-30 | $3.31K 10-K · filed 2017-12-29 |
| 2015-09-30 | $19.02K 10-K/A · filed 2017-12-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |